Crossword Solver > found answer > ELAGES

Welcome to Anagrammer Crossword Genius! Keep reading below to see if elages is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on elages.

CROSSWORD
ANSWER

ELAGES

Searching in Crosswords ...

The answer ELAGES has 0 possible clue(s) in existing crosswords.

Searching in Word Games ...

The word ELAGES is NOT valid in any word game. (Sorry, you cannot play ELAGES in Scrabble, Words With Friends etc)

Searching in Dictionaries ...

Definitions of elages in various dictionaries:

No definitions found

Word Research / Anagrams and more ...

check ELAGES in all word games (68 answers)
unscramble ELAGES (63 answers)
anagrams of ELAGES (26 answers)
words containing ELAGES (5 answers)
words starting with ELAGES (0 answers)
words ending with ELAGES (5 answers)
synonyms of ELAGES (0 answers)
antonyms of ELAGES (0 answers)

Keep reading for additional results and analysis below.

Elages might refer to
Elacestrant (INN) (developmental code names RAD-1901, ER-306323) is a nonsteroidal combined selective estrogen receptor modulator (SERM) and selective estrogen receptor degrader (SERD) (described as a "SERM/SERD hybrid (SSH)") that was discovered by Eisai and is under development by Radius Health and Takeda for the treatment of menopausal vasomotor symptoms (hot flashes) and estrogen receptor (ER)-positive advanced breast cancer, as well as endometrial cancer and kidney cancer. As of September 2016, it is in phase II clinical trials for vasomotor symptoms and breast cancer. Elacestrant has dose-dependent, tissue-selective estrogenic and antiestrogenic activities, with biphasic weak partial agonist activity at the ER at low doses and antagonist activity at higher doses. It shows agonistic activity on bone and antagonistic activity on breast and uterine tissues. Unlike the SERD fulvestrant, elacestrant is able to readily cross the blood-brain-barrier into the central nervous system, where it can target breast cancer metastases in the brain, and is orally bioavailable and does not require intramuscular injection.

Elages might refer to

Elacestrant (INN) (developmental code names RAD-1901, ER-306323) is a nonsteroidal combined selective estrogen receptor modulator (SERM) and selective estrogen receptor degrader (SERD) (described as a "SERM/SERD hybrid (SSH)") that was discovered by Eisai and is under development by Radius Health and Takeda for the treatment of menopausal vasomotor symptoms (hot flashes) and estrogen receptor (ER)-positive advanced breast cancer, as well as endometrial cancer and kidney cancer. As of September 2016, it is in phase II clinical trials for vasomotor symptoms and breast cancer. Elacestrant has dose-dependent, tissue-selective estrogenic and antiestrogenic activities, with biphasic weak partial agonist activity at the ER at low doses and antagonist activity at higher doses. It shows agonistic activity on bone and antagonistic activity on breast and uterine tissues. Unlike the SERD fulvestrant, elacestrant is able to readily cross the blood-brain-barrier into the central nervous system, where it can target breast cancer metastases in the brain, and is orally bioavailable and does not require intramuscular injection.

WAS THIS PAGE HELPFUL? Grab a CITATION

http://www.anagrammer.com/crossword/answer/elages

COPY